During the past decade, CH compiègne conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH compiègne" #1 sponsor was "Centre Hospitalier Universitaire, Amiens" with 8 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Centre Oscar Lambret" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH compiègne" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "CH compiègne" are "Cancer" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Breast Cancer" (2 trials), "Lymphoma" (2 trials) and "Alcoholic Hepatitis" (1 trials). Many other conditions were trialed in "CH compiègne" in a lesser frequency.

Most popular intervention types in "CH compiègne" are "Drug" (27 trials), "Other" (13 trials), "Radiation" (4 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "Placebo" (3 trials), "vinblastine sulfate" (3 trials), "Cyclophosphamide" (2 trials) and "bleomycin sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "CH compiègne" are 42 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CH compiègne". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in CH compiègne, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CH compiègne, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

CH compiègne has several departments that took part in Clinical trials: "CH Compiègne - Pneumologie" - 4 trials